 CAMBRIDGE, Mass., Nov. 04, 2021 GLOBE NEWSWIRE -- Vor Biopharma Nasdaq: VOR, a clinical-stage cell and genome engineering company, today announced the upcoming presentation of new data from its novel engineered hematopoietic stem cell eHSC platform at the American Society of Hematology ASH 63rd Annual Meeting, taking place in Atlanta, Georgia from December 11-14, 2021. 